Back to Search Start Over

Prophylactic Mesh Placement During Formation of an End-colostomy: Long-term Randomized Controlled Trial on Effectiveness and Safety.

Authors :
Brandsma, H.T.
Hansson, B.M.
Aufenacker, T.J.
Jong, N. de
Engelenburg, K.C.A. van
Mahabier, C.
Donders, R.
Steenvoorde, P.
Vries Reilingh, T.S. de
Westreenen, H.L. van
Wiezer, M.J.
Wilt, J.H.W. de
Rovers, M.M.
Rosman, C.
Brandsma, H.T.
Hansson, B.M.
Aufenacker, T.J.
Jong, N. de
Engelenburg, K.C.A. van
Mahabier, C.
Donders, R.
Steenvoorde, P.
Vries Reilingh, T.S. de
Westreenen, H.L. van
Wiezer, M.J.
Wilt, J.H.W. de
Rovers, M.M.
Rosman, C.
Source :
Annals of Surgery; e440; e446; 0003-4932; 3; 278; ~Annals of Surgery~e440~e446~~~0003-4932~3~278~~
Publication Year :
2023

Abstract

Contains fulltext : 295988.pdf (Publisher’s version ) (Closed access)<br />OBJECTIVE: The aim of this study was to determine if prophylactic mesh placement is an effective, safe, and cost-effective procedure to prevent parastomal hernia (PSH) formation in the long term. BACKGROUND: A PSH is the most frequent complication after stoma formation. Prophylactic placement of a mesh has been suggested to prevent PSH, but long-term evidence to support this approach is scarce. METHODS: In this multicentre superiority trial patients undergoing the formation of a permanent colostomy were randomly assigned to either retromuscular polypropylene mesh reinforcement or conventional colostomy formation. Primary endpoint was the incidence of a PSH after 5 years. Secondary endpoints were morbidity, mortality, quality of life, and cost-effectiveness. RESULTS: A total of 150 patients were randomly assigned to the mesh group (n = 72) or nonmesh group (n = 78). For the long-term follow-up, 113 patients were analyzed, and 37 patients were lost to follow-up. After a median follow-up of 60 months (interquartile range: 48.6-64.4), 49 patients developed a PSH, 20 (27.8%) in the mesh group and 29 (37.2%) in the nonmesh group ( P = 0.22; RD: -9.4%; 95% CI: -24, 5.5). The cost related to the meshing strategy was € 2.239 lower than the nonmesh strategy (95% CI: 491.18, 3985.49), and quality-adjusted life years did not differ significantly between groups ( P = 0.959; 95% CI: -0.066, 0.070). CONCLUSIONS: Prophylactic mesh placement during the formation of an end-colostomy is a safe procedure but does not reduce the incidence of PSH after 5 years of follow-up. It does, however, delay the onset of PSH without a significant difference in morbidity, mortality, or quality of life, and seems to be cost-effective.

Details

Database :
OAIster
Journal :
Annals of Surgery; e440; e446; 0003-4932; 3; 278; ~Annals of Surgery~e440~e446~~~0003-4932~3~278~~
Publication Type :
Electronic Resource
Accession number :
edsoai.on1399424399
Document Type :
Electronic Resource